Doximity (DOCS) Stock Price, News & Analysis

Company Overview

Doximity, Inc. (NASDAQ:DOCS) operates a secure, cloud-based professional network designed specifically for U.S. healthcare professionals. Founded in 2010 and headquartered in San Francisco, the company has grown to become one of the largest online communities for physicians, nurse practitioners, physician assistants and other medical practitioners. By offering a centralized platform for communication, collaboration and career development, Doximity aims to streamline clinical workflows and enhance patient care.

The company’s core offerings include a HIPAA-compliant telehealth solution, secure messaging, digital fax capabilities and a referral management system. Through its mobile and web applications, members can connect with colleagues, share patient cases, send encrypted messages, place digital faxes, and conduct video consultations with patients. Doximity also curates clinical news and research summaries through its DocNews feature, providing users with up-to-date information on medical breakthroughs and treatment guidelines.

In addition to clinician-facing tools, Doximity provides enterprise solutions for hospitals, health systems, medical practices and life sciences companies. Its Talent Solutions division assists healthcare organizations in recruiting and retaining physicians, while Media Solutions offers targeted advertising and marketing services to pharmaceutical and biotech clients. The company monetizes its platform through subscription fees, licensing of anonymized physician data and digital marketing campaigns, enabling more efficient provider outreach and engagement.

Leadership at Doximity includes co-founders Jeff Tangney, who serves as Chief Executive Officer, and Nate Gross, who oversees product development. Under their guidance, the company has expanded its user base to cover a significant portion of U.S. licensed physicians and advanced practitioners. Doximity completed its initial public offering in mid-2021 and continues to invest in product innovation and strategic partnerships to drive adoption across the healthcare industry.

Key Stats

• Today's Range: $59.33 to $61.70
• 50-Day Range: $50.78 to $61.69
• 52-Week Range: $25.00 to $85.21
• Volume: 1.06 million shs
• Average Volume: 2.17 million shs
• Market Capitalization: $11.59 billion
• P/E Ratio: 61.69
• Dividend Yield: N/A
• Price Target: $63.11
• Consensus Rating: Moderate Buy

Doximity Stock Analysis - MarketRank™

Doximity scored higher than 52% of companies evaluated by MarketBeat, and ranked 1534th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Doximity has received a consensus rating of Moderate Buy. The company's average rating score is 2.59, and is based on 9 buy ratings, 11 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Doximity has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 8.08%

Earnings Growth

Earnings for Doximity are expected to grow by 8.08% in the coming year, from $0.99 to $1.07 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Doximity is 61.69, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.56.

Price to Earnings Ratio vs. Sector

The P/E ratio of Doximity is 61.69, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.55.

Price to Earnings Growth Ratio

Doximity has a PEG Ratio of 4.10. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Doximity has a P/B Ratio of 11.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for DOCS.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Doximity does not currently pay a dividend.

Dividend Growth

Doximity does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for DOCS.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.81

News Sentiment

Doximity has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Doximity this week, compared to 11 articles on an average week.

Search Interest

Only 14 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -36% compared to the previous 30 days.

MarketBeat Follows

Only 4 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

Company Ownership

• Score: 4.2 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,100,770.00 in company stock.

Percentage Held by Insiders

37.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

87.19% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DOCS Stock Analysis - Frequently Asked Questions

How have DOCS shares performed this year?

Doximity's stock was trading at $53.39 at the beginning of the year. Since then, DOCS stock has increased by 15.5% and is now trading at $61.69.

How were Doximity's earnings last quarter?

Doximity, Inc. (NASDAQ:DOCS) posted its quarterly earnings data on Thursday, May, 15th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.11. The business's revenue was up 17.1% compared to the same quarter last year.

When did Doximity IPO?

Doximity (DOCS) raised $501 million in an initial public offering on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.

How do I buy shares of Doximity?

Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Doximity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Doximity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Tesla (TSLA), CrowdStrike (CRWD), PayPal (PYPL) and Invesco QQQ (QQQ).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/04/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Custom computer programming services
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:DOCS
• CIK: 1516513
• Web: www.doximity.com
• Phone: 650-549-4330
• Fax: N/A
• Employees: 890
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $63.11
• High Stock Price Target: $90.00
• Low Stock Price Target: $45.00
• Potential Upside/Downside: +2.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.59
• Research Coverage: 22 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.11
• Trailing P/E Ratio: 61.69
• Forward P/E Ratio: 62.31
• P/E Growth: 4.1
• Net Income: $147.58 million
• Net Margins: 36.60%
• Pretax Margin: 46.01%
• Return on Equity: 21.75%
• Return on Assets: 18.64%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 8.74
• Quick Ratio: 8.74

Sales & Book Value

• Annual Sales: $570.40 million
• Price / Sales: 20.31
• Cash Flow: $0.76 per share
• Price / Cash Flow: 81.32
• Book Value: $5.52 per share
• Price / Book: 11.18

Miscellaneous

• Outstanding Shares: 187,826,000
• Free Float: 116,869,000
• Market Cap: $11.59 billion
• Optionable: Not Optionable
• Beta: 1.37